{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:17Z","timestamp":1786119617482,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/mjt.0b013e3181f94c27","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T01:50:16Z","timestamp":1287798616000},"page":"223-225","source":"Crossref","is-referenced-by-count":3,"title":["Toxic Epidermal Necrolyis after Vancomycin Use"],"prefix":"10.1097","volume":"20","author":[{"given":"Avani","family":"Changela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemangkumar","family":"Javaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiersten","family":"Rickenback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Elnawawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinesh","family":"Changela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210202","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs.","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-14-20210202","first-page":"345","article-title":"Toxic epidermal necrolysis due to vancomycin.","volume":"68","author":"Vidal","year":"1992","journal-title":"Ann Allergy"},{"key":"R3-14-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/499367","article-title":". Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992 -2003.","volume":"42","author":"Klevens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R4-14-20210202","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":". Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis.","volume":"134","author":"Wolkenstein","year":"1996","journal-title":"Br J Dermatol"},{"key":"R5-14-20210202","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0190-9622(85)80012-8","article-title":"Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid pulse therapy.","volume":"12","author":"Sherertz","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"R6-14-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":". Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"key":"R7-14-20210202","first-page":"273","article-title":". Burn center care for patients with toxic epidermal necrolysis.","volume":"180","author":"Kelemen","year":"1995","journal-title":"J Am Coll Surg"},{"key":"R8-14-20210202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2230.1992.tb02163.x","article-title":"Toxic epidermal necrolysis treated with cyclosporin.","volume":"17","author":"Hewitt","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"R9-14-20210202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0190-9622(08)80969-3","article-title":"Efficacy of cyclophosphamide in toxic epidermal necrolysis: clinical and pathophysiologic aspects.","volume":"25","author":"Heng","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"R10-14-20210202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2230.1992.tb02163.x","article-title":"Toxic epidermal necrolysis treated with cyclosporin.","volume":"17","author":"Hewitt","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"R11-14-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":". Treatment of toxic epidermal necrolysis with cyclosporin A.","volume":"48","author":"Arevalo","year":"2000","journal-title":"J Trauma"},{"key":"R12-14-20210202","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1365-2133.1998.2576n.x","article-title":". Severe bullous drug reactions treated successfully with cyclophosphamide letter.","volume":"139","author":"Trautmann","year":"1998","journal-title":"Br J Dermatol"},{"key":"R13-14-20210202","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.1985.01660120074023","article-title":"Plasmapheresis in severe drug-induced toxic epidermal necrolysis.","volume":"121","author":"Kamanbroo","year":"1985","journal-title":"Arch Dermatol"},{"key":"R14-14-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":". Antitumour necrosis factor-antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"R15-14-20210202","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0305-4179(01)00005-5","article-title":". Treatment of drug-induced toxic epidermal necrolysis (Lyells syndrome) with intravenous human immunoglobulins.","volume":"27","author":"Paquet","year":"2001","journal-title":"Burns"},{"key":"R16-14-20210202","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":". Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"R17-14-20210202","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1097\/00003246-200211000-00029","article-title":". Recurrent fatal drug induced toxic epidermal necrolysis (Lyells syndrome) after putative -lactam cross-reactivity: case report and scrutiny of antibiotic imputability.","volume":"30","author":"Paquet","year":"2002","journal-title":"Crit Care Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-201303000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:43:32Z","timestamp":1786041812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201303000-00014"}},"subtitle":["A Case Report and Discussion of Management"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181f94c27","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}